Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2009
10/29/2009WO2009131704A2 Nanostructures suitable for sequestering cholesterol and other molecules
10/29/2009WO2009131687A2 Inhibitors of protein kinases
10/29/2009WO2009131201A1 Therapeutic agent for intermittent claudication
10/29/2009WO2009131170A1 Five-membered ring compound
10/29/2009WO2009131166A1 Wnt signaling inhibitor comprising insulin-like growth factor-binding protein
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130679A1 Benzimidazole derivatives as calcium channel blockers
10/29/2009WO2009130615A2 Use of deuterium oxide as an elastase inhibitor
10/29/2009WO2009129945A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
10/29/2009WO2009129833A1 Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect
10/29/2009WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
10/29/2009WO2009129696A1 A kind of receptor signaling transoluction positive modulators, preparation methods and uses thereof
10/29/2009WO2009129694A1 A new micelle formulation compriseing prostaglandin e1 entrapmented by polyglycol-derived phospholipid
10/29/2009WO2009106640A3 N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
10/29/2009WO2009105504A3 Functionally selective alpha2c adrenoreceptor agonists
10/29/2009WO2009093880A3 Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor
10/29/2009WO2009093208A3 Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
10/29/2009WO2009093206A3 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
10/29/2009WO2009046856A3 Use of serorphin as a therapeutic agent
10/29/2009WO2009046824A3 Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis
10/29/2009WO2009043505A3 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
10/29/2009WO2009043504A3 Use of apelin-36 and optionally beta-melanotropin as therapeutic agents, eg for treating aids or alzheimer
10/29/2009WO2009040089A3 Use of the peptides maippkknqdk (cow kappa casein 106-116) and/or ygfqna (serorphin) as therapeutic agents
10/29/2009WO2009039996A3 Use of bradykinin alone or in combination with melanotan ii as a therapeutic agent
10/29/2009WO2009039977A3 Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hbv infection
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009WO2009033781A3 Use of k237 as therapeutic agent
10/29/2009WO2009033751A3 Use of leu-enkephalin as a therapeutic agent
10/29/2009WO2009033718A3 Use of anti -inflammatory peptide 1 as a therapeutic agent
10/29/2009WO2009009173A3 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
10/29/2009US20090270592 Purified TNFR preparations
10/29/2009US20090270506 Crystalline structure of oxidosqualene synthase
10/29/2009US20090270495 Inhibitors of Phosphodiesterase Types 1 To 5 Based on Dioclein, Floranol, and Analogs Thereof
10/29/2009US20090270473 Dual-acting antihypertensive agents
10/29/2009US20090270464 Benzimidazole derivative and use as a II receptor antagonist
10/29/2009US20090270460 Fxr agonists
10/29/2009US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270427 Purine derivatives
10/29/2009US20090270426 P13 Kinase Antagonists
10/29/2009US20090270417 Organic Compounds
10/29/2009US20090270403 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
10/29/2009US20090270383 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270380 3,4,5-Substituted Piperidines as Renin Inhibitors
10/29/2009US20090270356 Compositions and treatments of heart failure in non-human mammal animals
10/29/2009US20090270331 Multi-domain amphipathic helical peptides and methods of their use
10/29/2009US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009US20090270322 G protein coupled receptor antagonists and methods of activating and inhibiting g protein coupled receptors using the same
10/29/2009US20090270314 Polypeptide having anti-angiogenic activity
10/29/2009US20090270313 Method of Treatment for Ischemic Heart Disease
10/29/2009US20090269424 Peripheral blood flow-improving composition
10/29/2009US20090269423 chinese herbal foot-bathing agent for treating hypertension and improving sleep quality, includes fructus leonuri 20-25%, semen ziziphi spinosae 15-20%, calcined magnetitum 17-22%, spica prunellae 15-20%, ligusticum chuanxiong hort 18-23%, and borneolum 0.7-1.2% by weight in the form of mixed powder
10/29/2009US20090269420 Substituted dihydropyrazolones and their use
10/29/2009US20090269410 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
10/29/2009US20090269389 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269316 Methods for Using a Three-Dimensional Stromal Tissue to Promote Angiogenesis
10/29/2009US20090269314 Human cardiovascular progenitor cells
10/29/2009US20090269310 Method for obtaining human smooth muscular cells and uses thereof
10/29/2009DE102008020053A1 Feste pharmazeutische Zubereitung enthaltend A solid pharmaceutical preparation containing 1-[(4-chloro-phenyl)-amid]-2-{[4-(3-oxo-morpholin-4-yl)-phenyl]-amid}-4-hydroxy-pyrrolidin-1,2-dicarbonsäure
10/29/2009CA2723185A1 Inhibitors of protein kinases
10/29/2009CA2722183A1 Nanostructures suitable for sequestering cholesterol and other molecules
10/29/2009CA2722139A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722067A1 Benzimidazole derivatives as calcium channel blockers
10/29/2009CA2722065A1 Use of deuterium oxide as an elastase inhibitor
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/28/2009EP2112161A2 Peptides that lower blood glucose levels
10/28/2009EP2112151A2 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/28/2009EP2111864A2 Therapeutic methods and uses of sapogenins and their derivatives
10/28/2009EP2111863A1 Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111262A2 1,3-dihydroimidazoles for treating cardiovascular disorders
10/28/2009EP2111228A2 Vegf pathway blockade
10/28/2009EP2111224A2 Targeting ncca-atp channel for organ protection following ischemic episode
10/28/2009EP1660066B1 Pharmaceutical composition comprising a combination of metformin and a statin
10/28/2009EP1609861B1 Low-molecular weight peptides inhibiting ion channel activity
10/28/2009EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1214057B1 Vascular coating composition
10/28/2009EP1098908B1 Anti-ccr2 antibodies and methods of use therefor
10/28/2009EP0975340B2 Therapeutic inhibitor of vascular smooth muscle cells
10/28/2009CN101565858A Composition containing peptide binding domain and method for forming nanoparticles and nanowires therefrom
10/28/2009CN101565445A Method for preparing high-purity veratramine and jervine
10/28/2009CN101565408A Receptor signal transduction positive modulator, preparation method and purpose thereof
10/28/2009CN101564536A Sustained and controlled release preparation for pharmaceutical composition for curing hypertension
10/28/2009CN101564505A Chinese medicament for treating pulmonary heart disease
10/28/2009CN101564504A Chinese medicament for treating pericarditis
10/28/2009CN101564503A Dizzy reducing and paralysis curing pill and preparation thereof
10/28/2009CN101564502A Oral liquid for treating cerebral palsy and preparation method thereof
10/28/2009CN101564501A Big activating collateral preparation and preparation method thereof
10/28/2009CN101564496A Plaster for mainly curing osteoarthropathy and soft tissue injury
10/28/2009CN101564491A Chinese medicament for treating diabetic retinopathy
10/28/2009CN101564476A Chinese medicament for treating coronary heart disease
10/28/2009CN101564448A Naotongqing
10/28/2009CN101564447A Medicament for curing apoplexy and preparation method thereof
1 ... 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 ... 1595